Denosumab
Open November ’12
Title: A randomised double-blind study of Denosumab V’s Zoledronic Acid (Zometa) in the treatment of bone disease in patients with Newly Diagnosed Multiple Myeloma.
Population: Patients with newly diagnosed MM who are for first line treatment and who have never received previous Intravenous biphosphonate treatment.
Resource Links
http://clinicaltrials.gov/ct2/show/NCT01345019
http://www.myeloma.org.uk/patient-services/faqs/new-myeloma-drugs-and-clinical-studies/
« Back